DK0866870T3 - Vævsfaktor-Kunitz-domæne-fusionsproteiner som inhibitorer for faktor Vlla - Google Patents

Vævsfaktor-Kunitz-domæne-fusionsproteiner som inhibitorer for faktor Vlla

Info

Publication number
DK0866870T3
DK0866870T3 DK96940592T DK96940592T DK0866870T3 DK 0866870 T3 DK0866870 T3 DK 0866870T3 DK 96940592 T DK96940592 T DK 96940592T DK 96940592 T DK96940592 T DK 96940592T DK 0866870 T3 DK0866870 T3 DK 0866870T3
Authority
DK
Denmark
Prior art keywords
factor
inhibitors
fusion proteins
domain fusion
kunitz domain
Prior art date
Application number
DK96940592T
Other languages
Danish (da)
English (en)
Inventor
Robert F Kelley
Robert A Lazarus
Geoffrey F Lee
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/566,800 external-priority patent/US5736364A/en
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK0866870T3 publication Critical patent/DK0866870T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK96940592T 1995-12-01 1996-11-22 Vævsfaktor-Kunitz-domæne-fusionsproteiner som inhibitorer for faktor Vlla DK0866870T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56645995A 1995-12-01 1995-12-01
US08/566,800 US5736364A (en) 1995-12-04 1995-12-04 Factor viia inhibitors
PCT/US1996/018756 WO1997020939A1 (en) 1995-12-01 1996-11-22 TISSUE FACTOR - KUNITZ DOMAIN FUSION PROTEINS AS FACTOR VIIa INHIBITORS

Publications (1)

Publication Number Publication Date
DK0866870T3 true DK0866870T3 (da) 2003-06-23

Family

ID=27074189

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96940592T DK0866870T3 (da) 1995-12-01 1996-11-22 Vævsfaktor-Kunitz-domæne-fusionsproteiner som inhibitorer for faktor Vlla

Country Status (8)

Country Link
EP (1) EP0866870B1 (de)
AT (1) ATE234359T1 (de)
AU (1) AU1023497A (de)
DE (1) DE69626671T2 (de)
DK (1) DK0866870T3 (de)
ES (1) ES2195025T3 (de)
PT (1) PT866870E (de)
WO (1) WO1997020939A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214333B1 (en) * 1997-07-08 2001-04-10 Texas Heart Institute Vasoprotective recombinant adenovirus vector containing a human TFPI gene
WO2000004148A1 (en) 1998-07-15 2000-01-27 Genentech, Inc. Tissue factor protein variants with increased affinity for coagulation factor fvii/fviia
AU781618C (en) 1999-07-02 2006-03-16 Genentech Inc. FVIIa antagonists
AU783087B2 (en) * 1999-08-06 2005-09-22 Genentech Inc. Peptide antagonists of factor VIIA
US6905683B2 (en) 2000-05-03 2005-06-14 Novo Nordisk Healthcare A/G Human coagulation factor VII variants
RU2326126C2 (ru) 2000-09-13 2008-06-10 Ново Нордиск Хелт Кэр Аг Полипептид фактора vii свертывания крови, его получение и применение
WO2002038162A1 (en) 2000-11-09 2002-05-16 The Scripps Research Institute MODIFIED FACTOR VIIa
US7052868B2 (en) 2001-09-27 2006-05-30 Novo Nordisk Healthcare A/G Human coagulation factor VII polypeptides
US6960657B2 (en) 2001-11-02 2005-11-01 Novo Nordisk Healthcare A/G Human coagulation factor VII polypeptides
US7164002B2 (en) 2002-02-06 2007-01-16 Genentech, Inc. FVIIa antagonists
US6911323B2 (en) 2002-09-25 2005-06-28 Novo Nordisk Healthcare A/G Human coagulation factor VII polypeptides
CN101870729A (zh) 2003-09-09 2010-10-27 诺和诺德医疗保健公司 凝固因子ⅶ多肽
ES2353084T3 (es) * 2006-04-07 2011-02-25 Novo Nordisk Health Care Ag Complejo covalente de factor vii y factor tisular.
EP4225373A4 (de) * 2020-10-07 2025-01-08 Dren Bio, Inc. Anti-dectin-1-antikörper und verfahren zur verwendung davon
US20240108688A1 (en) 2020-11-20 2024-04-04 Universitätsmedizin Der Johannes Gutenberg-Universität Mainz Inhibitors of the tissue factor-protease activated receptor 2 (TF-PAR2) signaling pathway for use in the treatment or prevention of heart failure (HF) and associated or resulting diseases
GB202402535D0 (en) * 2024-02-22 2024-04-10 Imperial College Innovations Ltd Fusion proteins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0439442T3 (da) * 1990-01-25 1996-07-08 Univ Washington Faktor X-LACI-hybridprotein
US5346991A (en) * 1991-06-13 1994-09-13 Genentech, Inc. Tissue factor mutants useful for the treatment of myocardial infarction and coagulopathic disorders
AU7050994A (en) * 1993-06-01 1994-12-20 Scripps Research Institute, The Human mutant tissue factor compositions useful as tissue factor antagonists
US5795954A (en) * 1994-03-04 1998-08-18 Genentech, Inc. Factor VIIa inhibitors from Kunitz domain proteins

Also Published As

Publication number Publication date
ES2195025T3 (es) 2003-12-01
PT866870E (pt) 2003-08-29
DE69626671T2 (de) 2004-03-18
DE69626671D1 (de) 2003-04-17
EP0866870B1 (de) 2003-03-12
WO1997020939A1 (en) 1997-06-12
EP0866870A1 (de) 1998-09-30
AU1023497A (en) 1997-06-27
ATE234359T1 (de) 2003-03-15

Similar Documents

Publication Publication Date Title
AU1023497A (en) Tissue factor - kunitz domain fusion proteins as factor viia inhibitors
DK0760661T3 (da) Farmaceutiske sammensætninger omfattende en opiat-antagonist og calciumsalte, deres anvendelse til behandling af endorfin-m
MY125150A (en) Factor vlla inhibitors
DE69805973D1 (de) Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin-abhängigen protein kinase
DK0719154T3 (da) Aktiveret faktor VIII som terapeutisk middel og metode til behandling af faktor VIII-mangel
TR199801151T2 (xx) Trombin inhibit�r� �n ila�lar.
RU95108387A (ru) Дикетопиперазин, способ его получения, фармацевтическая композиция, применение дикетопиперазина
PL373903A1 (en) A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease
GEP20012388B (en) Metalloproteinase Inhibitors, Pharmaceutical Compositions on Their Base, Use and Methods for Obtaining and Intermediates
BR9908280A (pt) Inibidores de enzimas de fosfolipase
ATE333896T1 (de) Vaskularisierungsinhibitoren
NZ324887A (en) Piperazine and piperidine compounds with analgesic effect
WO2001041753A3 (en) Therapeutic compositions and methods for treating periodontitis with antiinflamatory compounds
MY124648A (en) Inhibitor of factor xa alone or in combination with an anti-platelet aggregation agent, for combating arterial thrombosis.
DK0691858T3 (da) Tokomponent fibrinklæber
ATE291914T1 (de) Zolmitriptanhaltige arzneizusammensetzungen
SE9802208D0 (sv) Novel compounds
BR0110506A (pt) Uso de inibidores de il-18 para o tratamento e/ou prevenção da aterosclerose
NO20004419L (no) Ny anvendelse
ATE266420T1 (de) Kombinationspräparat, das selektive nmda nr2b- antagonisten und cox-2 inhibitoren enthält
BR9811298A (pt) Uso de um composto de vanádio fisiologicamente aceitável
YU16399A (sh) ) UPOTREBA INHIBITOR H +, K+ - ATP- aze I FARMACEUTSKA FORMULACIJA ZA SIMULTANU, SEPARATNU ILI SEKVENCIJALNU UPOTREBU, KOJA SADRZI INHIBITOR H +, K+-ATP- aze I GLUKOKORTIKOID INHIBITOR H +, K+- ATP- aze
DE69819539D1 (de) Antithrombotische mittel
SE9802209D0 (sv) Novel compounds
BR0108980A (pt) Aplicação e formulação farmacêuticas compreendendo inibidor de reabsorção de norepinefrina